Prospective comparison of outcomes with azacitidine and decitabine in patients with AML ineligible for intensive chemotherapy

作者：Amer M. Zeidan, Pierre Fenaux, Marco Gobbi, Jiřı́ Mayer, Gail J. Roboz, Jürgen Krauter, Tadeusz Robak, Hagop M. Kantarjian, Jan Novák, W Wiktor-Jędrzejczak, Xavier Thomas, Mario Ojeda‐Uribe, Yasushi Miyazaki, Yoo Hong Min, Su‐Peng Yeh, Joseph Brandwein, Liana Gercheva, Judit Demeter, Elizabeth A. Griffiths, Karen Yee, Jean‐Pierre J. Issa, Jan Philipp Bewersdorf, Harold Keer, Yong Hao, Mohammad Azab, Hartmut Döhner · 发表于：Blood · 年份：2022 · DOI：10.1182/blood.2022015832 · 被引用次数：39 · 研究领域：Acute Myeloid Leukemia Research、Histone Deacetylase Inhibitors Research、Hematopoietic Stem Cell Transplantation